Showing results (1391-1400 of 1,453) with videos related to

Sort By:
Pageof 146
Annals of Surgery|February 21, 2018
Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 TrialJin-Young Jang, Youngmin Han, Hongeun Lee, et al.
European Journal of Gastroenterology & Hepatology|May 1, 2009
Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005Jin Il Kim, Sang Gyun Kim, Nayoung Kim, et al.
Annals of Surgical Oncology|April 19, 2014
Surgical strategy for T1 gallbladder cancer: a nationwide multicenter survey in South KoreaSeung Eun Lee, Jin-Young Jang, Sun-Whe Kim, et al.
Gut and Liver|September 7, 2017
Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer AlgorithmsYoung-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|September 10, 2017
Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinomaMasaki Kaibori, Masanori Kon, Tomoki Kitawaki, et al.
Transplantation and Cellular Therapy|July 7, 2024
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With LymphomaRachel Lorenc, Roni Shouval, Jessica R Flynn, et al.
Digestive Diseases and Sciences|December 24, 2014
Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III TrialEun Hye Kim, Yong Chan Lee, Young Woon Chang, et al.
BMC Gastroenterology|December 19, 2023
Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority studyHyun Lim, Jong Kyu Park, Hyunsoo Chung, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Tenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis BYun Bin Lee, Eun Uk Jung, Bo Hyun Kim, et al.
Bone Marrow Transplantation|February 1, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphomaMagdalena Corona, Andrew Ip, Samantha Brown, et al.
Pageof 146